Phillips Andrew John 4
4 · Enliven Therapeutics, Inc. · Filed Feb 10, 2025
Insider Transaction Report
Form 4
Phillips Andrew John
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-06+20,491→ 20,491 totalExercise: $22.47Exp: 2035-02-06→ Common Stock (20,491 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2025 annual meeting of the Issuer's stockholders or (ii) the date of the 2026 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.